BFF
ABBV icon

Byrne Financial Freedom’s AbbVie ABBV Stock Holding History

Byrne Financial Freedom’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Sell
1,307
-45
-3% -$9.98K 0.14% 88
2025
Q4 		$309K Buy
1,352
+15
+1% +$3.42K 0.14% 84
2025
Q3 		$310K Sell
1,337
-650
-33% -$132K 0.15% 77
2025
Q2 		$369K Sell
1,987
-13
-0.7% -$2.42K 0.18% 68
2025
Q1 		$419K Buy
2,000
+100
+5% +$19.4K 0.24% 57
2024
Q4 		$338K Buy
+1,900
New +$349K 0.15% 73

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Byrne Financial Freedom's ABBV Position: Q1 2026 in Review

Byrne Financial Freedom reduced its AbbVie (ABBV) stake by 3.3% in Q1 2026, selling an estimated $9.98K and leaving 1,307 shares worth $284K. The position accounts for 0.14% of the portfolio, ranked #88.

Byrne Financial Freedom first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $419K in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Byrne Financial Freedom held 1,307 shares of AbbVie worth $284K as of Q1 2026.
  • Byrne Financial Freedom sold 45 AbbVie shares in Q1 2026, an estimated $9.98K.
  • AbbVie made up 0.14% of Byrne Financial Freedom's portfolio in Q1 2026, its #88 holding.
  • Byrne Financial Freedom first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Byrne Financial Freedom's AbbVie position peaked at $419K in Q1 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Byrne Financial Freedom's 13F filing for Q1 2026, filed 27 Apr 2026.